Our growing portfolio of joint venture companies pursuing AI-based drug discovery with the Atomwise discovery engine provides new opportunities for licensing and investment.
Fueling Innovation with AI-based Drug Discovery
The synergy of the biology exploration by our partners and chemical exploration with our AtomNet® technology creates discoveries that will advance therapies for disease areas with unmet needs.
Interested in Our Portfolio Companies?
Contact us to invest in or license from our portfolio companies.